Literature DB >> 22412178

Modified adenotonsillectomy to improve cure rates for pediatric obstructive sleep apnea: a randomized controlled trial.

Michael Friedman1, Christian G Samuelson, Craig Hamilton, Alexander Maley, David Taylor, Kanwar Kelley, Kristine Pearson-Chauhan, Colleen Hoehne, Adam J LeVay, T K Venkatesan.   

Abstract

OBJECTIVE: To compare the efficacy of adenotonsillectomy (T&A) with and without pharyngoplasty (tonsillar pillar closure) in the treatment of pediatric obstructive sleep apnea-hypopnea syndrome (OSAHS). STUDY
DESIGN: Randomized single-blind controlled study.
SETTING: Tertiary care center. SUBJECTS AND METHODS: Sixty pediatric patients with a clinical diagnosis of OSAHS presenting between January 2009 and December 2010 were enrolled and randomized to undergo either standard T&amp;A (n = 30) or T&amp;A with pharyngoplasty (n = 30). Surgical cure was defined as apnea-hypopnea index (AHI) <5 plus OSA-18 health-related quality-of-life (HRQL) score <60. Other outcomes included postsurgical AHI and minimum oxygen saturation (SpO(2)) improvement, changes in OSA-18 scores at 1 month, and postsurgical days to resume normal diet and activity.
RESULTS: Three patients from each group did not undergo surgery. Of the 54 patients treated, 8 from the pharyngoplasty group and 2 from the standard group were lost to follow-up. Intention-to-treat analysis revealed no difference in cure rate between groups (standard 60%, pharyngoplasty 56.6%, P = .793). Limiting analysis to those patients with complete data, a higher, but not significantly increased, cure rate with pharyngoplasty was noted (72% vs 89.5%, P = .155). Greater OSA-18 improvement (P = .036) and greater (although nonsignificant) AHI improvement and earlier return to normal function were noted with pharyngoplasty.
CONCLUSION: The addition of pharyngoplasty to traditional adenotonsillectomy did not significantly improve OSAHS cure rates as measured by sleep testing and HRQL, although a nonsignificant increase in cure rate was observed in those who completed the study protocol. An unexpectedly high rate of patient dropout rendered the study statistically underpowered and therefore inconclusive.

Entities:  

Mesh:

Year:  2012        PMID: 22412178     DOI: 10.1177/0194599812440666

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Adenopharyngoplasty vs Adenotonsillectomy in Children With Severe Obstructive Sleep Apnea: A Randomized Clinical Trial.

Authors:  Johan Fehrm; Pia Nerfeldt; Joar Sundman; Danielle Friberg
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

2.  Effects of low-temperature plasma treatment on pulmonary function in children with obstructive sleep apnea-hypopnea syndrome.

Authors:  Xiaoyong Wang; Yehai Liu; Guanglei Tang; Hui Wang; Yi Zhao
Journal:  Ir J Med Sci       Date:  2019-11-18       Impact factor: 1.568

3.  Long-term parental satisfaction with adenotonsillectomy: a population study.

Authors:  Wojciech Kukwa; Andrzej Kukwa; Adam Galazka; Anna M Czarnecka; Antoni Krzeski; Ewa Migacz; Stacey L Ishman
Journal:  Sleep Breath       Date:  2015-03-06       Impact factor: 2.816

4.  Using cone beam CT to assess the upper airway after surgery in children with sleep disordered breathing symptoms and maxillary-mandibular disproportions: a clinical pilot.

Authors:  Noura A Alsufyani; Michelle L Noga; Manisha Witmans; Irene Cheng; Hamdy El-Hakim; Paul W Major
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-04-11

5.  Postoperative morbidity after adenotonsillectomy versus adenopharyngoplasty in young children with obstructive sleep apnea: an RCT.

Authors:  Johan Fehrm; Anna Borgström; Pia Nerfeldt; Danielle Friberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-16       Impact factor: 2.503

6.  Efficacy of pillar suture for post-tonsillectomy morbidity in children: a meta-analysis.

Authors:  Ji-Sun Kim; Byung Guk Kim; Dong-Hyun Kim; Se Hwan Hwang
Journal:  Braz J Otorhinolaryngol       Date:  2020-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.